By: Tetsuya Tanimoto, MD Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation Director of Navitas Clinic Kawasaki In the ever-evolving world of metabolic health management, we stand at a peculiar, almost mystical crossroads. On one side, a line-up of cutting-edge pharmaceuticals, the stars of which are GLP-1 receptor agonists, have appeared, almost from thin air. These drugs—sleek, precise, and modern—promise a life free from constant hunger and the w

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The new coronavirus vaccine "Costaive," developed by Meiji Seika Pharma (a subsidiary of Meiji Holdings), has garnered significant public attention. Social media is flooded with misinformation, including claims that vaccinated individuals can infect others through 'shedding'. Meiji has initiated defamation lawsuits against anti-vaccine groups that have led the spread of these falsehoods.

Tetsuya Tanimoto, M.D. Medical Governance Research Institute, Tokyo, Japan In spring 2023, our pharmaceutical conflicts of interest research group participated in an international conference in Bath, UK. There, we had the pleasure of meeting Professor Tom Fahey from the Royal College of Surgeons in Ireland. While Ireland is a small nation with an estimated population of 5.28 million in 2023, it boasts a young demographic and impressive economic metrics. According to the IMF,

福岛医科大学放射健康管理系教授 坪仓正治 這是該系列的第500版，自发表至今已近10年了。向一直以來支持我們的大家，以及每週都在截止日期前工作到最後一刻的編輯部的各位，表示衷心的感謝。 與10年前相比，縣民需要获取的资讯和关心的興趣發生了變化，縣外談論的有關輻射的資訊也發生...

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Anything made by humans cannot eliminate the...

Kana Yamamoto, M.D., Ph.D Physician, Medical Governance Research Institute The Japan Meteorological Agency (※1) announced on August 1st...

Accessible Rail Medical Services Tetsuikai, Navitas Clinic Kawasaki, Tetsuya Tanimoto, MD GLP-1 receptor agonists are very popular around...

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan However, this incident occurred in Fukushima, Mr. Munakata's home prefecture. Perhaps he had an interest due to it being about his hometown. He said, "Since a junior asked," and introduced me to an excellent female staff member. She came to the medical research lab at Tokyo University and spent about two hours listening to the situation. After hearing my explanation, she said, "It's not

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan I recently had the opportunity to revisit the 2006 arrest incident of an obstetrician at Fukushima Prefectural Ohno Hospital. This was due to assisting Yuria Iyano, a student from Yokohama City University Medical School, with her report. Ms. Iyano chose to study under Professor Suzuki at the Graduate School of Public Policy, University of Tokyo, as part of her external training curriculu

Mutsuko Ohnishi, MD, Internal medicine physician in Boston, USA Researchers from Harvard University reported in September last year that...

Masaharu Tsubokura, M.D., Ph.D. Chief Professor, Department of Radiation Health Management, School of Medicine, Fukushima Medical...

Makoto Kosaka, Orange Home-care Clinic I have completed my initial training and now work at the Orange Home Care Clinic, specializing in...

Makoto Kosaka, Orange Home-care Clinic I am a third-year medical resident, working at the Orange Home Care Clinic in Fukui City, Fukui...

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The collective strike by medical residents in South Korea has become a topic of global discussion. Not only has it been covered by our national media, but on April 4th, the "New York Times" in the United States also published an extensive explanatory article. Why has such a situation arisen in South Korea? This paper aims to discuss the background. Increasing Medical Demand in South Kore

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The Kobayashi Pharmaceutical red yeast rice issue has sparked discussions about the safety of health foods, highlighting that Japan is following a trend already established in the U.S. two decades ago. Part of Abenomics, the functional food labeling system initiated in April 2015, was modeled after the U.S.'s Dietary Supplement Health and Education Act (DSHEA) established in 1994. This